# Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

> **NCT02491632** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 90 (actual)

## Conditions studied

- Advanced Malignant Neoplasm
- Fatigue
- Metastatic Malignant Neoplasm
- Recurrent Malignant Neoplasm
- Refractory Malignant Neoplasm

## Interventions

- **DRUG:** Dexamethasone
- **BEHAVIORAL:** Exercise Intervention
- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT02491632
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-08-13
- **Primary completion:** 2019-03-28
- **Final completion:** 2026-12-31
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02491632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02491632, "Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02491632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*